TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2214590

Group type: EXPERIMENTAL
Intervention: HM + HMP
Number of subjects: 25

Group type: COMPARATOR
Intervention: HM + PH
Number of subjects: 25
Study: 308770

Group type: EXPERIMENTAL
Intervention: Sensory-stimulating treatment for eight weeks
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sedentary activities for eight weeks (Control)
Number of subjects: 7
Study: 30777844

Group type: EXPERIMENTAL
Intervention: Go‐breath app with alarm function (test group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Go‐breath app without alarm function (control group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Go‐breath app (both groups)
Number of subjects: 44
Study: 28753384

Group type: EXPERIMENTAL
Intervention: Cabazitaxel 20 mg/m2 (C20)
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Cabazitaxel 25 mg/m2 (C25)
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m2 (D75)
Number of subjects: 1168
Study: 26017725

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no physical rehabilitation)
Number of subjects: 20
Study: 24574930

Group type: EXPERIMENTAL
Intervention: Facebook group with psychiatrist as 'friend'
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Facebook group without psychiatrist as 'friend'
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no Facebook use)
Number of subjects: 60
Study: 22743344

Group type: EXPERIMENTAL
Intervention: Fibre post insertion within composite build‐up before cementation of indirect composite onlay restorations
Number of subjects: 0

Group type: COMPARATOR
Intervention: No fibre post insertion
Number of subjects: 0
Study: 20142279

Group type: EXPERIMENTAL
Intervention: Intervention novel (describes an overweight girl who discovers improved health and self‐efficacy)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control novel
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Either book (intervention or control)
Number of subjects: 81
Study: 17610525

Group type: EXPERIMENTAL
Intervention: Verbal and written information in Vietnamese
Number of subjects: 95

Group type: COMPARATOR
Intervention: Routine verbal counselling in English
Number of subjects: 95
Study: 15625211

Group type: EXPERIMENTAL
Intervention: Clozapine + Risperidone (up to 6 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clozapine + Placebo
Number of subjects: 40
Study: 12169075

Group type: COMPARATOR
Intervention: Multivitamin-mineral supplementation
Number of subjects: 652

Group type: COMPARATOR
Intervention: Vitamin E supplementation (200 mg)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 652
Study: 10440514

Group type: EXPERIMENTAL
Intervention: Intermittent hemodialysis (HD) - one 4‐h session and Kt/V > or = 1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Continuous veno‐venous hemofiltration (CVVH) - one 24‐h session and Kt/V > or = 1
Number of subjects: 12
Study: 8723585

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (150 IU/kg subcutaneously on alternate days; six doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epoetin alfa combined with normovolemic hemodilution (NVHD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2054690

Group type: EXPERIMENTAL
Intervention: Midazolam 10 mg intramuscularly
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazepam 15 mg intramuscularly
Number of subjects: 60
Study: 6338998

Group type: EXPERIMENTAL
Intervention: Trichloracetic acid (50%) and podophyllin (25%)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Podophyllin (25%) alone
Number of subjects: 73
Study: 31825024

Group type: EXPERIMENTAL
Intervention: Oral health education sessions delivered by trained schoolteachers
Number of subjects: 435

Group type: COMPARATOR
Intervention: Control group (no extra oral health education)
Number of subjects: 435
Study: 28120629

Group type: EXPERIMENTAL
Intervention: ropinirole PR 8 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ropinirole PR 12 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 25827078

Group type: EXPERIMENTAL
Intervention: Subcutaneous suture only without subcuticular skin suture (case group, n=68)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Subcutaneous suture and subcuticular skin suture (control group, n=70)
Number of subjects: 138
Study: 23873992

Group type: EXPERIMENTAL
Intervention: Boys (early neonatal mortality)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Girls (late neonatal mortality)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biological factors (early neonatal mortality)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Environmental factors (late neonatal mortality)
Number of subjects: 0
Study: 21106341

Group type: EXPERIMENTAL
Intervention: Hypertonic saline and dextran (HSD)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 113
Study: 19249945

Group type: EXPERIMENTAL
Intervention: Ropinirole (0.25-6 mg)
Number of subjects: 1679

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1679
Study: 16752943

Group type: EXPERIMENTAL
Intervention: Hexylaminolevulinate 4 mmol/L
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hexylaminolevulinate 8 mmol/L
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hexylaminolevulinate 16 mmol/L
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hexylaminolevulinate (all concentrations)
Number of subjects: 12
Study: 14737056

Group type: EXPERIMENTAL
Intervention: Humalog (insulin lispro)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Regular human insulin
Number of subjects: 71
Study: 11719362

Group type: EXPERIMENTAL
Intervention: Orbofiban (oral GPIIb/IIIa antagonist)
Number of subjects: 1014

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1014

Group type: EXPERIMENTAL
Intervention: Orbofiban
Number of subjects: 1014
Study: 1402941

Group type: EXPERIMENTAL
Intervention: latex/latex gloving protocol
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: latex/cloth gloving protocol
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: latex/cloth/latex gloving protocol
Number of subjects: 267

Group type: COMPARATOR
Intervention: All protocols
Number of subjects: 267
Study: 3907640

Group type: COMPARATOR
Intervention: Clenbuterol 10 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Clenbuterol 20 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Salbutamol 8 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30221305

Group type: EXPERIMENTAL
Intervention: Task-oriented training on a tilt table
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (conventional upper limb training)
Number of subjects: 45
Study: 27178781

Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 266

Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 266
Study: 24617449

Group type: EXPERIMENTAL
Intervention: SRP with aPDT
Number of subjects: 90
Study: 22699436

Group type: EXPERIMENTAL
Intervention: FSME-IMMUN® Junior
Number of subjects: 0

Group type: COMPARATOR
Intervention: Encepur® Children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FSME-IMMUN® Junior (third vaccination)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FSME-IMMUN® Junior or Encepur® Children (first two vaccinations) followed by FSME-IMMUN Junior® (third vaccination)
Number of subjects: 0
Study: 21106812

Group type: EXPERIMENTAL
Intervention: Active cognitive emotion regulation task during fMRI
Number of subjects: 34

Group type: COMPARATOR
Intervention: Passive viewing task after 15 min delay
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Active cognitive emotion regulation task
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Correlational analyses
Number of subjects: 34
Study: 18283224

Group type: EXPERIMENTAL
Intervention: Square-stepping exercise (SSE)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Strength and balance (SB) training
Number of subjects: 39
Study: 15305178

Group type: EXPERIMENTAL
Intervention: trans‐18:1 isomers (T fat)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: saturated fats (P fat and S fat)
Number of subjects: 16

Group type: COMPARATOR
Intervention: oleic acid (O fat)
Number of subjects: 16

Group type: COMPARATOR
Intervention: linoleic acid (L fat)
Number of subjects: 16
Study: 12794400

Group type: EXPERIMENTAL
Intervention: Discard volume of 2 times the deadspace
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Discard volume of 3.6 times the deadspace
Number of subjects: 84

Group type: COMPARATOR
Intervention: All discard volumes tested
Number of subjects: 84
Study: 10834505

Group type: EXPERIMENTAL
Intervention: Preoperative hypervolaemic haemodilution using hydroxyethyl starch, followed by intraoperative crystalloid infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard intraoperative normovolaemic fluid balance management using crystalloids
Number of subjects: 8
Study: 8794967

Group type: EXPERIMENTAL
Intervention: 2-phase oil:water mouthrinse
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control mouthrinse
Number of subjects: 50
Study: 2005168

Group type: EXPERIMENTAL
Intervention: Local injections of corticosteroid and local anaesthesia
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Manipulation and injection
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Coccygectomy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 120
Study: 3927764

Group type: EXPERIMENTAL
Intervention: Lysine acetylsalicylate 1.8 g in 10 ml of saline intravenously
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo injection of 10 ml of saline intravenously
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 40
Study: 31624844

Group type: EXPERIMENTAL
Intervention: phosSNPs (specifically rs3184504 at SH2B3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SH2B3 expression level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma beta-2-microglobulin level
Number of subjects: 0
Study: 30203763

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine Kouchuang Xiaotong powder
Number of subjects: 140

Group type: COMPARATOR
Intervention: General routine treatment
Number of subjects: 140
Study: 26890802

Group type: EXPERIMENTAL
Intervention: 595-nm pulsed-dye laser (PDL) with high fluence
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 595-nm pulsed-dye laser (PDL) with low fluence
Number of subjects: 62
Study: 23820566

Group type: EXPERIMENTAL
Intervention: 1 stair (1S) training
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 2 stairs (2S) training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (C) group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 40-m sprint split power
Number of subjects: 14
Study: 22440070

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 174
Study: 21270182

Group type: EXPERIMENTAL
Intervention: Insulin lispro mix 75/25 (LM75/25)
Number of subjects: 1818

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 1818
Study: 18044772

Group type: EXPERIMENTAL
Intervention: Miconazole 50-mg mucoadhesive buccal tablet (MBT)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Miconazole 500-mg oral gel (MOG)
Number of subjects: 282
Study: 16752875

Group type: EXPERIMENTAL
Intervention: Vaginal and abdominal surgical correction of descensus uteri
Number of subjects: 82
Study: 12635389

Group type: EXPERIMENTAL
Intervention: Midazolam 0.015 mg/kg i.v.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (normal saline i.v.)
Number of subjects: 60
Study: 10714405

Group type: EXPERIMENTAL
Intervention: Children with epilepsy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 71
Study: 8885027

Group type: EXPERIMENTAL
Intervention: Reminder efforts for non-attenders
Number of subjects: 2510

Group type: COMPARATOR
Intervention: Cervical cancer screening participation
Number of subjects: 2510
Study: 1391062

Group type: EXPERIMENTAL
Intervention: Recombinant interferon alpha-2c (6 micrograms, subcutaneously 3 times a week for 6 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Recombinant interferon gamma (0.1 mg, subcutaneously 3 times a week for 6 weeks)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 33
Study: 3977198

Group type: EXPERIMENTAL
Intervention: Intervention: Treatment algorithm to increase patient involvement in care during a 20-minute session before a scheduled visit.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control: Standard educational session of equal length.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention: Treatment algorithm to increase patient involvement in care.
Number of subjects: 0
Study: 31155413

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 272
Study: 29785878

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI plus medical therapy
Number of subjects: 888

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 888
Study: 27965848

Group type: EXPERIMENTAL
Intervention: Oral feeding plus pre-treatment gastrostomy tube
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral feeding plus as-needed nasogastric tube feeding
Number of subjects: 60
Study: 25217473

Group type: EXPERIMENTAL
Intervention: Intranasal ketamine 2 mg/kg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Intranasal alfentanil 10 µg/kg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Isotonic saline 1 ml
Number of subjects: 78
Study: 23236769

Group type: EXPERIMENTAL
Intervention: Xiaochuangao acupoint paste (XAP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Hormone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: XAP and Hormone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All three groups (XAP, Hormone, XAP and Hormone)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: XAP and Hormone vs Hormone
Number of subjects: 90
Study: 20078514

Group type: COMPARATOR
Intervention: Diclofenac sodium suppository
Number of subjects: 90

Group type: COMPARATOR
Intervention: Periprostatic injection of levobupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Diclofenac suppository and levobupivacaine
Number of subjects: 90
Study: 18562365

Group type: EXPERIMENTAL
Intervention: Plain X-rays
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MRI evaluation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Frykman Type VI and VIII fractures
Number of subjects: 60
Study: 16199711

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo saline solution
Number of subjects: 108
Study: 12369732

Group type: EXPERIMENTAL
Intervention: EGb 761 (120 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 70
Study: 9925116

Group type: EXPERIMENTAL
Intervention: Lipid infusion (11.97 kJ/min, or 2.86 kcal/min)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glucose infusion (11.97 kJ/min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control infusion (saline)
Number of subjects: 20
Study: 7478706

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: General Anesthesia
Number of subjects: 18
Study: 2297824

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Aminophylline after intracoronary adenosine infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7358209

Group type: EXPERIMENTAL
Intervention: Hydroderm ointment base (1% hydrocortisone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established hydrocortisone ointment formulation
Number of subjects: 0
Study: 31541747

Group type: EXPERIMENTAL
Intervention: serlopitant
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 30202902

Group type: EXPERIMENTAL
Intervention: Dietary omega-3 fatty acids (fish oil)
Number of subjects: 7

Group type: COMPARATOR
Intervention: High-ω-3 diet
Number of subjects: 7
Study: 28330830

Group type: EXPERIMENTAL
Intervention: Web-based survey (n=2300 GPs in France, n=300 GPs in Switzerland)
Number of subjects: 3400

Group type: COMPARATOR
Intervention: Postal survey (n=400 GPs in France, n=700 GPs in Switzerland)
Number of subjects: 3400
Study: 25283139

Group type: EXPERIMENTAL
Intervention: B-vitamins supplementation (vitamin D3 1200 IU, folic acid 500 μg, vitamin B12 500 μg, vitamin B6 50 mg, calcium carbonate 456 mg)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: B-vitamins supplementation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (vitamin D3 plus calcium carbonate)
Number of subjects: 59
Study: 23341476

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 21884221

Group type: EXPERIMENTAL
Intervention: Novel reasoning task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-culturally validated categories
Number of subjects: 0
Study: 20008251

Group type: EXPERIMENTAL
Intervention: Erythropoiesis stimulating agents (ESAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNA methyltransferase inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Azacitidine
Number of subjects: 0
Study: 16865032

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for adolescents (IPT‐A)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Treatment as usual delivered by school‐based mental health clinicians (Control)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both IPT‐A and Control
Number of subjects: 63
Study: 12626974

Group type: EXPERIMENTAL
Intervention: Ketamine-midazolam
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sufentanil-midazolam
Number of subjects: 25
Study: 10671342

Group type: EXPERIMENTAL
Intervention: Symptomatic genital herpes (n=10)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Asymptomatic genital herpes (n=11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Newborns of mothers with HSV
Number of subjects: 21
Study: 9058688

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide, 800 microg two times a day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 31
Study: 8470789

Group type: EXPERIMENTAL
Intervention: Etomidat‐Lipuro
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hypnomidate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Diprivan (Propofol)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All three groups
Number of subjects: 120
Study: 2951261

Group type: COMPARATOR
Intervention: Doxazosin (1, 2, 4, 8 or 16 mg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Atenolol (50 or 100 mg)
Number of subjects: 39
Study: 29572201

Group type: EXPERIMENTAL
Intervention: Hearing aid use for the first time during a 6-month auditory training program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Auditory training (active control)
Number of subjects: 40
Study: 27151999

Group type: EXPERIMENTAL
Intervention: Psychoanalytic therapy (PA)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy (PD)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 3
Study: 24735894

Group type: EXPERIMENTAL
Intervention: Ice Bag Technique (IBT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional methods
Number of subjects: 150
Study: 22197217

Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis of 37 biomarkers
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Multivariable Cox‐proportional hazard regression analyses
Number of subjects: 236
Study: 21040556

Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient clinic including a brief group-based educational programme
Number of subjects: 400

Group type: COMPARATOR
Intervention: Regular care with individual outpatient consultation with a rheumatologist (treatment as usual)
Number of subjects: 400
Study: 18673365

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg QW
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 15307859

Group type: EXPERIMENTAL
Intervention: Endoscopic balloon dilation (EPBD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endoscopic biliary sphincterotomy (EST)
Number of subjects: 0
Study: 11124745

Group type: EXPERIMENTAL
Intervention: 10% triacylglycerol emulsion infusion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 32
Study: 9643859

Group type: EXPERIMENTAL
Intervention: Zinc lozenges, 10 mg, orally dissolved, 5 times a day (grades 1-6) or 6 times a day (grades 7-12)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Zinc lozenges
Number of subjects: 249
Study: 8163780

Group type: EXPERIMENTAL
Intervention: Mean Diurnal Variation (MDV)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: MDV
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Medication requirements
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Methacholine reactivity
Number of subjects: 74
Study: 3278366

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Antacid
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 27178060

Group type: EXPERIMENTAL
Intervention: Integrated Brain, Body, and Social (IBBS) intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 92
Study: 29223688

Group type: EXPERIMENTAL
Intervention: Color Doppler imaging
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard ultrasound imaging
Number of subjects: 150
Study: 27686234

Group type: EXPERIMENTAL
Intervention: Single incision sleeve gastrectomy (SI)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional laparoscopic sleeve gastrectomy (CL)
Number of subjects: 130
Study: 25662105

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 86